| Target Price | CN¥45.84 |
| Price | CN¥31.02 |
| Potential |
47.79%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target China International Capita-h 2027 .
The average China International Capita-h target price is CN¥45.84.
This is
47.79%
register free of charge
CN¥60.22
94.12%
register free of charge
CN¥40.60
30.89%
register free of charge
|
|
| A rating was issued by 12 analysts: 8 Analysts recommend China International Capita-h to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the China International Capita-h stock has an average upside potential 2027 of
47.79%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | 31.11 | 37.23 |
| 34.18% | 19.65% | |
| Net Margin | 29.10% | 39.85% |
| 35.01% | 36.94% |
7 Analysts have issued a sales forecast China International Capita-h 2026 . The average China International Capita-h sales estimate is
This results in the following potential growth metrics:
8 China International Capita-h Analysts have issued a net profit forecast 2026. The average China International Capita-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | 1.88 | 3.07 |
| 80.77% | 63.30% | |
| P/E | 10.62 | |
| EV/Sales | 8.75 |
8 Analysts have issued a China International Capita-h forecast for earnings per share. The average China International Capita-h EPS is
This results in the following potential growth metrics and future valuations:
China International Capita-h...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


